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Abstract
Objective Despite earlier diagnosis and advancements in
treatment, cancer remains a leading cause of death in the
world (13% of all deaths according to the World Health
Organization) among men and women. Cancer accounts for
approximately 20% of the deaths in the USA every year.
Here, we report the findings from a cross-sectional survey
of psychosocial factors in lung and gastrointestinal cancer
patients. The aim of the study was to explore the
associations among transitoriness, uncertainty, and locus
of control (LOC) with quality of life. Transitoriness is
defined as a person’s confrontation with life’s finitude due
to a cancer diagnosis.
Methods A total of 126 patients with lung or gastrointes-
tinal cancer completed eight self-reporting questionnaires
addressing demographics, spiritual perspective, symptom
burden, transitoriness, uncertainty, LOC, and quality of life.
Results Transitoriness, uncertainty, and LOC were signifi-
cantly associated with one another (r=0.3267, p=0.0002/r=
0.1994, p=0.0252, respectively). LOC/belief in chance has a
significant inverse relationship with patients’ quality of life
(r=−0.2505, p=0.0047). Transitoriness, uncertainty, and LOC
were found to have a significant inverse relationship with
patients’ quality of life (transitoriness state: r=−0.5363, p=
0.0000/trait: r=−0.4629, p=0.0000/uncertainty: r=−0.4929,
p=0.0000/internal LOC: r=0.1759, p=0.0489/chance LOC:
r=−0.2505, p=0.0047).
Conclusion Transitoriness, uncertainty, and LOC are im-
portant concepts as they adversely influence patients’
quality of life. Incorporating this finding into the care of
cancer patients may provide them with the support they
need to cope with treatment and maintenance of a positive
quality of life.
Keywords Cancer . Psychosocial issues .
Cross-sectional survey . Gastrointestinal and lung cancer
patients . Transitoriness . Quality of life
Introduction
The fact that cancer may be fatal remains one of its most
significant characteristics [1]. In particular, many patients
with lung and gastrointestinal (GI) cancer have a poor
prognosis [2]. Annually, approximately 300,000 men and
women die of lung or GI cancer in the USA [2]. As a result,
these patients face life’s transitoriness, which constitutes an
important aspect of life after a cancer diagnosis [3, 4].
Transitoriness describes cancer patients’ realization that
they may die as a result of their disease and that death may
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come sooner than expected. Fear of death is part of this
experience, but patients tend to emphasize their fear of
burdening their families with the potentiality for death [5].
Qualitative studies indicate that a sense of transitoriness
finds expression in increased anxiety, anger, uncertainty [5,
6], and a perception of lessened control, which, in turn, may
lead to impaired self-confidence and even depression [7, 8].
Transitoriness also contributes to an increased motivation
for change and keen interest in life, as manifested in altered
life priorities and goals [5, 6]. Eventually, patients aim to
find a way to accept death as part of the disease and to
incorporate this awareness into their everyday life [1]. They
become aware that they need to put their affairs in order, to
ensure that the household will continue to function, and/or
that family and friends are not left with unsolvable and
insurmountable problems [4, 9].
Besides the confrontation with life’s finitude, psycho-
logical factors such as uncertainty, anxiety, and distress can
significantly and adversely influence cancer patients’
quality of life [10, 11]. Uncertainty is defined in this
context as people’s ability to determine the meaning of
illness-related events [12]. Being confronted with uncer-
tainty can motivate people to attempt to adjust to the
changing demands associated with their illness [12, 13].
These studies have focused predominantly on cancer
survivors, women with breast cancer or men with prostate
cancer [14, 15]. Cancer patients also experience changes in
locus of control [16]. The term “locus of control” (LOC)
refers to where individuals believe their control to be
regarding their health [17]. A higher degree of control over
decisions and a higher level of influence over the illness
situation are assumed to positively affect individuals’
quality of life. Validation studies conducted by Wallston
[17, 18] with patients with arthritis, chronic pain, diabetes,
and cancer indicated that cancer patients had a higher belief
in chance1 than patients with other chronic diseases. A
cross-sectional study employing a convenience sample of
95 African American demonstrated that a higher belief in
powerful others was related to a greater self-esteem [7].
Quality of life in cancer patients has often been studied
regarding treatments and symptoms [19, 20]. However,
patients’ sense of transitoriness and its relationship to
uncertainty, LOC, and quality of life as symptoms of a
cancer diagnosis in patients with lung and GI cancer have
yet to be examined in detail. Studies concerning the sense
of transitoriness due to a cancer diagnosis and its influence
on patients’ quality of life have been predominantly
qualitative in nature [1, 21]. Information about the sense
of transitoriness is necessary if we are to fully comprehend
how patients experience their disease and cancer treatment.
Therefore, a cross-sectional study was conducted to explore
the interrelationships among transitoriness, uncertainty,
LOC, and quality of life in lung and GI cancer patients.
In particular, we have addressed the hypotheses that cancer
patients’ sense of transitoriness is related to uncertainty and
LOC and that their sense of transitoriness, uncertainty, and
LOC is negatively associated with quality of life.
Patients and methods
Study design and setting
This cross-sectional study was conducted at the Sidney
Kimmel Comprehensive Cancer Center and the Bayview
Medical Center at the Johns Hopkins Medical Institutions
(Baltimore, MD, USA), a large teaching facility in the
USA, and was approved by its institutional review board.
Patients
A total of 193 patients with a diagnosis of lung or GI cancer at
various stages who visited the Center between May 2006 and
August 2007 were enrolled in the study. The inclusion criteria
for this study were: (a) of any ethnic group, (b) >21 years of
age, (c) able to speak and read English, (d) inpatient or
outpatient at this teaching facility, (e) not in hospice care.
Patients were approached by study team members while they
were inpatients or were waiting for consultations or treat-
ments. After patients had signed the consent form, they
received the set of questionnaires described below and then
completed them either on site or at home.
Instruments
The four main variables in this study, i.e., a sense of
transitoriness, uncertainty, LOC, and quality of life, were
assessed by means of five questionnaires administered to
the patients. Two other questionnaires were used to assess
patients’ physical symptoms and spiritual practices.
Transitoriness
Scales for assessing transitoriness have yet to be developed,
but patients’ fear of death after a cancer diagnosis has been
assessed in the past by using anxiety measures such as the
State–Trait Anxiety Scale [22]. This scale has been
enhanced to include measures for the states and traits of
anger, depression, and curiosity [23]. This instrument,
therefore, was considered to provide information on the
attributes of transitoriness, i.e., fear of death, anger at the
situation, curiosity for life, and a potential for depression as
a result of an overwhelming sense of transitoriness [3, 5].
1 The subscale ‘chance LOC’ measures the extent to which patients
believe their health and illness situation is due to luck and chance [8].
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The State–Trait Personality Inventory is valid with a
reliability of r=0.78 to r=0.90 [24] and consists of eight
Likert-based subscales, each totaling in ten items. The
responses range from 80 to 320 points. Higher scores
indicate a stronger sense of transitoriness.
Uncertainty
Mishel’s Uncertainty in Illness scale [25] was used to
measure uncertainty, i.e., the extent to which people are
able to determine the meaning of disease-related events
[12]. This Likert-type questionnaire consists of 33 items,
with responses ranging from 32 to 160 points with higher
scores indicating more uncertainty. This is a valid instru-
ment with a reliability of r=0.90 [25].
Locus of control
The Multidimensional Health LOC Scale [17] was
employed to measure patients’ perception of LOC, i.e.,
the extent to which people believe their health is dependent
on their behavior [17]. There are three different forms of
this scale: namely A, B, and C. Forms A and B are
purported to be interchangeable and measure people’s
general beliefs about health LOC. The recommendation is
to always use form C, which is condition specific, in
conjunction with either A or B [26]. Forms B and C were
used. Form B encompasses three subscales: internal LOC,
chance, and powerful others. Form C encompasses four
subscales: internal LOC, chance, doctors, and other people
LOC [27]. Form B’s Cronbach’s α ranges from 0.60 to 0.70
[26]; form C’s Cronbach’s α ranges from 0.70 to 0.87.
These two forms together consist of 36 Likert scale items,
with responses ranging from six to 36 for the subscales
internal, chance, and powerful others of forms B/C and
from 6 to 18 for the subscales doctors and other people
responses. Neither form B nor C adds up to a total score,
but higher scores indicate higher levels of control.
Quality of life
The Functional Assessment of Cancer Therapy (FACT-G)
developed by Cella et al. [28] was used to assess patients’
quality of life. The FACT-G version 4 measures people’s
subjective assessment of their physical, social, emotional,
and functional well-being. The FACT-G version 4 consists
of 27 items with a five-point Likert-type response scale
with a Cronbach’s α of 0.80 [28]. The scores for the
physical, social, and functional well-being subscales range
between 0 and 28. The scores of the emotional well-being
subscale range between 0 and 24. The sum score for the
total scale ranges from 0 to 108 [28]. Higher scores indicate
increased quality of life.
Other instruments
Patients’ symptom burden was assessed using the MD
Anderson Symptom Inventory (MDASI) [29]. This scale
assesses current symptoms in addition to the related distress
and interference in usual activities [29]. The MDASI
consists of 13 Likert-type questions with responses ranging
from 0 to 130, and higher scores indicate increased
symptom burden. Participants also provided an overview
of their spiritual practices with the Spiritual Perspective
Scale [30]. This scale measures people’s views and
behaviors that are due to the people’s belief in some
dimension of transcendence or a spiritual guide beyond
human beings [30]. It consists of ten Likert-type questions
with responses ranging from 10 to 60 with higher scores
indicating more frequent spiritual practice.
Data analysis
Data were entered and analyzed using Stata Intercooled 9®,
a software package for descriptive and inferential statistics.
Apart from the demographics scale, sum scores were
calculated according to the manuals and specifications of
the questionnaire developers. The findings obtained from
these instruments were analyzed using means and standard
deviations, calculated for the whole sample and women and
men separately. Pearson correlations between quality of life
and transitoriness, uncertainty, and LOC were calculated
separately, with p values of ≤0.05 being considered
significant. Multivariate linear regression was used to
assess the potential associations between transitoriness and
quality of life after adjusting for sex and disease site.
Findings
Demographics
Of the 193 cancer patients enrolled in the present study,
39% (n=75) completed the set of questionnaires on site.
The remainder (n=118) completed them elsewhere, and
33% (n=64) of these patients mailed their set of question-
naires back. Of the 139 returned questionnaires, 65.3% (n=
126) were fully completed and usable for analysis. This
overall response rate was achieved by follow-up phone
calls by the study team.
The final sample size was n=126 (51% women) with an
average age of 61.4 years (SD=9.59; men: mean =
61.7 years, SD=9.27; women: mean = 61.1 years, SD=
9.95), and 80% were married. The majority of the
participants were Caucasian (89%). The ethnic variability
in this sample reflected the demographics of the center
where the study was conducted.
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Colorectal, lung, and pancreatic cancer were almost
equally represented in the study population. A total of 35
participants (40%women) had been diagnosed with colorectal
cancer, 38 (55%women) with lung cancer, and 30 (50%men)
with pancreatic cancer. A fourth group of 23 patients (61%
women) had liver (22%), stomach (39%), gallbladder (35%),
or anal cancer (4%). The majority of the participants (34%;
60% women) presented with stage IV disease. Stage I was
identified in 11 patients (27% women), stage II in 12 patients
(33% women), and stage III in 29 patients (48% women). In
the case of 31 patients (55% women), the disease was not
staged. Among those with colorectal, lung, or pancreatic
cancer, more than half presented with stage IV disease. In the
group with various cancer diseases, only a third presented
with stage IV disease. Three quarters of the participants had
been diagnosed <15 weeks prior to study enrollment (mean =
14.79, SD=22.90). The majority of our participants (73%)
had had a surgical intervention and were undergoing
chemotherapy treatment (92.9%); less than half the partic-
ipants were in radiation therapy (46.8%). About half of all
participants (n=58) were receiving a combination of chemo-
therapy and radiation. Only nine patients had neither
received chemotherapy nor radiation therapy treatments. A
symptom burden of 41.48 (SD=30.20; range = 0–121) for
the whole sample (n=126) indicated that patients suffered
from at least four symptoms out of a total of 13, whether
physical, such as nausea, or psychosocial, such as impaired
mood. Women’s (n=64) mean symptom burden was 41.86
(SD=29.02) and men’s (n=62) was 43.06 (SD=31.90). The
participants most frequently noted fatigue (mean = 3.66, SD=
3.84), reduction on their ability for general activity (mean =
3.25, SD=2.85), and restricted household work (mean = 3.21,
SD=2.97). The least concern was vomiting (mean = 0.52,
SD=1.46).
Eighty-two percent of the participants (52 women; 51
men) reported Christian faith. Across all participants, a
mean of 43.58 (SD=14.09) for the Reed Spiritual Perspec-
tive Scale [30] was obtained. Women (n=64, mean = 46.07,
SD=13.79) reported a slightly higher level of spiritual
practice than men (n=62, mean = 41.18, SD=14.07), but
this difference was only marginally significant (t=−1.9215,
degrees of freedom =118, p=0.0571; Table 1).
Nonresponders
Of the 193 patients approached, a total of 67 patients (35
women) did not complete the survey. The majority of these
patients experienced disease progression, which prevented
them from participating in the study. The average age of the
nonresponders was 61.66 years (range 32–87 years).
Approximately, half of these patients (n=32) were married,
but over a third did not indicate their marital status (n=26).
Similarly, the majority of these patients (n=48) did not
provide information on their educational background.
However, 15 patients indicated undergraduate and higher
education. More than two thirds of the patients (n=44) did
not indicate their spiritual affiliation. A third of the patients
(n=21) stated that they were of Christian faith; one person
was of the Islamic and one person of the Jewish faith. The
majority of the nonresponders were Caucasian (n=43)
along with one Hispanic and one Asian person. Unfortu-
nately, 17 African Americans decided against participation
due to concerns about confidentiality.2 Of the nonrespond-
Table 1 Demographics of the study population (n=126)
Variables All (n=126)
Gender
Women 64
Men 62
Age in years [mean (SD)] 61.36 (9.59)
Marital relations
Married 101
Divorced 8
Widowed 8
Single 9
Ethnicity
Caucasian 111
African–American 9
Asian 2
Hispanic 2
Other 1
Disease stage
Stage 1 11
Stage 2 12
Stage 3 29
Stage 4 43
Not staged 31
Symptom burden [mean (SD)]a 42.45 (30.35)
Religious affiliation
Christian 103
Muslim 1
Jewish 8
Other 14
Spirituality [mean (SD)]b 43.58 (14.09)
The numbers in the table are counts
a Score on the MD Anderson Symptom Inventory [47]
b Score on the Spiritual Perspective Scale [48]
2 There was a passage in the standard consent form employed by the
Johns Hopkins Medical Institutions that the participant’s general/
family practitioner outside the hospital may be informed of health care
data if requested. For the African American people, this particular
passage was unacceptable, and no satisfactory alternative could be
found.
274 Support Care Cancer (2011) 19:271–279
ers, 16 patients had been diagnosed with bile duct cancer;
n=13 patients had lung cancer, and an equal group (n=13)
were patients with colorectal cancer. However, 24 patients
did not identify the cancer site.
Transitoriness
The mean sum score for the state portion of the State–Trait
Personality Inventory [24] was 75.64 (SD=13.39) and for
the trait portion was 77.15 (SD=11.11). Overall, men and
women demonstrated approximately the same levels of
state and trait transitoriness. However, men tentatively had
higher trait transitoriness than women (p=0.0506). Equally,
men had higher levels of trait anger than women (p=
0.0456). The neutral depression threshold in the state part
was given at mean = 14.37 (SD=5.89) for men and mean =
14.79 (SD=5.05) for women [24]. A mean of 19.57 (SD=
6.90) for men and a mean of 22.18 (SD=7.05) for women
indicated mild depression [24]. With regard to our sample,
neither men nor women were close to the mild depression
level given as the threshold for state depression. For trait
depression threshold, mean = 17.58 (SD=6.57) for men and
mean = 18.52 (SD=5.88) for women were reported [24].
These values were greater than the ones of our participants.
Cronbach’s α was calculated as 0.9307 for the state portion
and 0.9383 for the trait portion (Table 2).
Uncertainty
The uncertainty scale sum score was calculated for 32 items
as indicated by Mishel [12]. Our study participants (n=126)
demonstrated a mean uncertainty level of 87.31 (SD=
10.41), with a 95% confidence interval of [85.47; 89.16].
Their perception of the situation’s ambiguity was calculated
at 32.62 (SD=9.13), and the complexity was found to be
27.04 (SD=3.45). The study participants considered the
inconsistency of the information at 14.59 (SD=3.17) and
the illness’ unpredictability at 13.06 (SD=3.64). Men
demonstrate a mean level of uncertainty of 87.32 (SD=
9.50) and are similar to women with a mean of 87.29 (SD=
11.30). Cronbach’s α was 0.8728.
Locus of control
Medium levels emerged for men and women regarding
internal LOC, chance, and powerful others. The findings of
the “doctors” subscale indicated that the study participants
relied on health care professionals, whereas other people
appeared to have a less important role regarding LOC. Men
and women differed in the levels of LOC. Only the
difference between LOC and “significant others” emerged
as significant (p=0.0035). Cronbach’s α was 0.6458 for
form B and 0.7980 for form C (Table 3).
Quality of life
In this sample (n=126), the mean self-reported level of
quality of life as measured by the FACT-G was 41.64 (SD=
8.91). The men report a mean level of quality of life of 42.15
(SD=9.66), and the women reported a slightly lower mean
of 40.99 (SD=8.53). Cronbach’s α was 0.9142 (Table 4).
Association among the main variables
No significant differences were found among patients with
lung, colorectal, pancreatic, and other GI cancer regarding
transitoriness, uncertainty, LOC, or quality of life. Calculation
of the Pearson correlations demonstrated significant inverse
associations between quality of life and transitoriness,
uncertainty, and chance LOC. A significant positive relation-
ship was found between quality of life and internal LOC. In
addition, quality of life was found to be inversely correlated
with symptom burden as measured by the MDASI, transito-
riness, and uncertainty. Findings with p values of <0.05 are
reported (Table 5).
Multivariate linear regression was used to assess the
association between quality of life and transitoriness while
adjusting for gender and cancer site. After adjustment, the
multivariate linear regression analysis results were found to
explain 32% (r-squared) or 30% (adjusted r-squared) of the
variance in quality of life (F (4, 121)=14.23, p=0.0000) for
our sample of n=126 (Table 6).
Discussion
Overall, the levels of transitoriness state and trait, uncer-
tainty, and LOC in our population were found to be
moderate to high in comparison to the norms provided by
Spielberger [24], Mishel [12], and Wallston [17, 18] on the
respective measurements. This study sample consisted of an
Table 2 Transitoriness in the study population (n=126)
Transitoriness Present study [mean (SD)]
Men (n=62) Women (n=64)
State anxiety 18.58 (6.19) 18.38 (5.91)
Trait anxiety 17.02 (5.82) 16.69 (4.74)
State anger 12.56 (4.65) 11.89 (3.57)
Trait anger 16.26 (4.71) 14.81 (3.21)
State curiosity 27.40 (5.76) 26.89 (5.58)
Trait curiosity 30.23 (5.82) 28.67 (6.21)
State depression 18.24 (6.12) 17.37 (5.81)
Trait depression 15.61 (5.85) 15.08 (4.94)
Support Care Cancer (2011) 19:271–279 275
even number of men and women. Among this sample, lung
and GI cancer are evenly distributed. The majority of the
study participants had stage IV disease. This may be due to
the group of patients with pancreatic cancer. Most of our
study population had been diagnosed with stage IV disease
fewer than 15 weeks prior to participation. A majority of
the participants also were undergoing surgical intervention,
chemotherapy, and/or radiation therapy. The levels of state
and trait transitoriness and uncertainty in the study
participants may be thus explained. Having cancer is
exceedingly stressful [10], produces high levels uncertainty
[9, 10], and induces anxiety [10], anger [31], and a sense of
transitoriness [1, 5]. Being in treatment for cancer is
considered highly stressful, provoking anxiety and uncer-
tainty depending on the extent of the changes in body and
lifestyle due to the disease, as well as the degree of
involvement patients experience in treatment decision-
making processes [32, 33].
In this sample, surprisingly, the depression levels were
not found to exceed the mild depression threshold [24].
However, because information concerning the specifics of
medication or antidepression treatment were not collected,
it is difficult to interpret these findings clinically. Never-
theless, depression remains an important psychosocial
symptom that is prevalent in cancer patients and influences
the coping process [7, 10].
The study participants experienced high levels of
uncertainty (mean = 87.31, SD=10.41). Three quarters of
our sample had received the diagnosis of cancer less than
15 weeks prior to participation in the study. Also, the
majority of the study participants were undergoing antican-
cer treatment. These aspects may explain the levels of
uncertainty in the study participants. Uncertainty has been
found among patients with prostate cancer who are
undergoing watchful waiting [34, 35] or among survivors
of breast cancer [15]. Among the latter group, the uncertainty
levels (mean = 57.08, SD=10.14) were lower than the ones of
our study participants [15]. Undergoing anticancer treatment
has been described as being a distressing situation for
patients and their families, as the situation is found to be
unstable and not predictable [32, 33].
The LOC levels in our sample do not exceed the referential
data provided by Wallston [17, 18] that were obtained upon
the validation processes of forms B and C. Our study
participants’ LOC levels as assessed by form B were slightly
lower than the ones found in Taiwanese cancer patients [36]
and the ones found in African American cancer patients [37].
Evidence exists that higher belief in chance, i.e., to what
extent people believe that their health and illness situation is
due to pure luck and chance, may influence screening
practices for breast cancer among women [38, 39]. It can be
argued that the importance of belief in chance that was found
in our sample may also be due to the many unknown aspects
of lung and GI cancer and that investigations into the
etiology of the cancer may not produce conclusive results
[40, 41]. These uncertainties associated with cancer and its
etiology are considered difficult to accept and may impair
patient coping [7].
In our sample, the significant association among a sense
of transitoriness, uncertainty, and LOC supports results
from qualitative studies that indicate such a relationship [1,
5, 9]. A sense of transitoriness, uncertainty, and LOC
showed a statistically significant inverse correlation with
quality of life. The interrelationship of uncertainty with
quality of life in this sample (r=−0.4929, p=0.0000) was
congruent with that reported in the literature (r=−0.462)
[13]. Similarly, research employing the positive and
negative affect schedule has indicated a relationship (r=
0.26) between quality of life and LOC [42, 43]. However,
All (n=126) Women (n=64) Men (n=62)
Mean (SD) Mean (SD) Mean (SD)
Quality of life (FACT) 41.56 (9.08) 40.99 (8.53) 42.15 (9.66)
Subscale physical well-being 19.17 (5.82) 18.52 (5.64) 19.84 (5.98)
Subscale social/family well-being 11.44 (2.39) 11.49 (2.21) 11.39 (2.58)
Subscale emotional well-being 6.25 (1.65) 6.29 (1.51) 6.20 (1.79)
Subscale functional well-being 4.70 (1.67) 4.69 (1.61) 4.71 (1.76)
Table 4 Quality-of-life results
for the study population
Table 3 Locus of control (LOC) results for the study population
(n=126)
Present study [mean (SD)]
Men (n=62) Women (n=64)
LOC form B
Internal 24.52 (4.41) 22.66 (5.90)
Chance 16.48 (5.81) 18.37 (5.36)
Powerful others 24.87 (5.10) 23.23 (5.50)
LOC form C
Internal 17.65 (6.80) 16.55 (6.57)
Chance 17.40 (8.00) 20.09 (7.65)
Doctors 15.05 (2.40) 14.41 (2.58)
Other people 11.92 (3.61) 9.94 (3.842)
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studies have not yet shown that patients’ belief in chance
significantly reduces their perception of quality of life.
Studies focusing on this factor may yield important
information, enabling a better understanding of cancer
patients.
Although our study was sufficiently powered, stratifica-
tion of the results by cancer site was not possible because
each of the four disease groups in this sample was too
small. In addition, the majority of the participants were
Caucasian. Although the study was open to all patients
from diverse ethnic backgrounds, only a very small number
of African American, Hispanic, and Asian people could be
enrolled. Further investigation of the potential effect of the
type of cancer on the parameters assessed here including
ethnic group is necessary in order to enable us to determine
their relationship to transitoriness. Although transitoriness
has been associated with patient outcomes such as quality
of life [44], the extent to which this relationship was
observed in the present study is surprising. The fact that
transitoriness accounted for 32% of the variability in quality
of life is a novel finding. These results suggest that
psychosocial factors are important for all patients and need
to be considered if quality cancer care is to be provided. In
future studies, the association of transitoriness with other
psychosocial factors in patients with other cancers, such as
head and neck cancer, and of diverse ethnic backgrounds
should be examined along with various psychosocial
factors and their association with quality of life over time.
Conclusion
The findings from this cross-sectional study demonstrate that
patients with lung and GI cancer experience medium to high
levels of transitoriness, uncertainty, and LOC, which adverse-
ly influence patients’ quality of life. Therefore, it is important
to consider these factors as psychosocial symptoms and
include them in cancer care. It is necessary not only to assess
physical symptoms systematically and periodically but also
psychosocial factors including a sense of transitoriness,
uncertainty, and LOC coupled with inquiries as to the patients’
current worries and preoccupations.
Further study of a sense of transitoriness, uncertainty,
LOC, and their relationship to quality of life in lung and GI
cancer patients over the disease trajectory in relation to
other symptoms is necessary in order to obtain a more
thorough understanding of the patients’ experience and
needs. Thus, it will be possible to develop and implement
instruments that help to systematically assess these factors
on a regular basis to gain a better understanding of patients’
quality of life and their coping with the disease. More
comprehensive information about the disease situation can
be obtained, which can lead to earlier recognition of
clinically relevant anxiety or depression. In addition,
clinically relevant resources such as patient curiosity or
support by significant others may be identified. This would
provide for earlier and important referrals to be obtained if
necessary.
Dependent variable Independent variables Correlation
Transitoriness state Uncertainty r=0.3267, p=0.0002
Transitoriness trait Uncertainty r=0.2678, p=0.0024
Transitoriness state Chance locus of control (form B) r=0.1994, p=0.0252
Transitoriness trait Chance locus of control (form B) r=0.2280, p=0.0102
Quality of life (FACT) Transitoriness state r=−0.5363, p=0.0000
Quality of life (FACT) Transitoriness trait r=−0.4629, p=0.0000
Quality of life (FACT) Uncertainty r=−0.4929, p=0.0000
Quality of life (FACT) Internal locus of control (Form B) r=0.1759, p=0.0489
Quality of life (FACT) Chance locus of control (Form B) r=−0.2505, p=0.0047
Quality of life (FACT) Chance locus of control (Form C) r=−0.1816, p=0.0418
Quality of life (FACT) Symptom burden r=−0.6701, p=0.0000
Table 5 Statistically significant
correlations among the main
variables (n=126)
p values ≤0.05 for variable 1 vs.
variable 2 were considered
significant
Quality of life (FACT) Coef. Std. err. T P>¦t¦ 95% conf. interval
Sex −2.28 1.39 −1.64 0.103 −5.02 0.47
Cancer site −0.47 0.64 −0.74 0.46 −1.75 0.80
Transitoriness State −0.28 0.07 −3.82 0.000 −0.42 −0.13
Transitoriness Trait −0.16 0.09 −1.80 0.075 −0.34 0.02
_cons 77.35 5.43 14.26 0.00 66.60 88.09
Table 6 Transitoriness and
quality of life (n=126)
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